Summary
46 / 100 · Bulios Score
Valuation 100Growth -Profitability -Quality 0Debt 80Stability 1
What speaks for it
- It has no debt and holds $2.42M in cash.
What to watch
- It passes only 2 of the 9 points of the Piotroski financial health test.
- The price moves much more than the market (beta 4.05).
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks cheapIs it growing?
Revenue (USD)
201920202021202220232025
Diluted EPS (USD)
2019202020212022202320252026
- Analyst estimate
There is not enough revenue history yet to say how fast it grows.
Growth in detailDoes it make money?
Income figures for the last 12 months are not available.
Profitability in detailIs it financially healthy?
YesCash and short-term investments $2.42M
Debt $0.00
It has no debt.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
Mildly positive- Buy 2
- Hold 2
- Sell 0
Today's price within the analysts' price targets
Today's price $0.0001 Average target $3.33
$0.0001 $5
The average target of $3.33 is 3,329,900% above today's price. 50% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
By product
The company reports no revenue by product.
By region
The company reports no revenue by region.